Yomna M. Meligui-El
Cairo, C 11976, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Journal: Oncology research
Published: June 20, 2023
Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: April 22, 2023
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Journal: International journal of immunopathology and pharmacology
Published: May 27, 2022
Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.
Journal: Pharmacogenomics and personalized medicine
Published: March 30, 2022
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 10, 2021
Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.
Journal: Pharmacogenomics and personalized medicine
Published: September 23, 2020
Combined Expression of CD34 and FLT3-Internal Tandem Duplication Mutation Predicts Poor Response to Treatment in Acute Myeloid Leukemia.
Journal: International journal of general medicine
Published: August 12, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026